Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 33 Neoplasms 5 Colorectal Neoplasms 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Neoplasm Metastasis 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Locally Advanced Pancreatic Adenocarcinoma 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

Gemcitabine 95 Cisplatin 63 Oxaliplatin 40 pembrolizumab 30 Fluorouracil 29 Capecitabine 28 lenvatinib 24 durvalumab 24 Leucovorin 23 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Radiotherapy 10 Drug Therapy 10 pemigatinib 9 apatinib 9 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡